logo Hematology/Oncology Research Studies: Open for Enrollment Date: 05/27/20


Anti-Sickling Agents

NCT#/Phase: N/A
IRB#: 2016-054
Description: The purpose of this study is identify chemical compounds that will decrease the speed of sickling of red blood cells that could be made into medicine for people with sickle cell disease.
Inclusion: Individuals 7 years of age or older with sickle cell diseae who have their blood drawn during a routine clinic visit.
Enrollment Status: Open for enrollment
Sponsor: UCSF Benioff Children's Hospital Oakland
Principal Investigator(s): Anne Marsh, MD
Frans Kuypers, PhD
Contact(s): Kacie Smith (510-428-3885 x2752)

Study Link: #

UCSF Benioff Children's Hospital Oakland • 747 52nd Street, Oakland, California 94609 &bull Phone: (510) 428-3000